top of page
Medical Checkup

INCYTE

Trial Enrolment Status

OPEN

Disease Under Study

ASTHMA

Duration

~28 Weeks

About the Trial

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Mechanism of Action:

JAK1 Inhibitor

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Nusrat Jahan

bottom of page